Coston, Mc Isaac & Partners Moderna, Inc. Transaction History
Coston, Mc Isaac & Partners
- $288 Million
- Q1 2025
A detailed history of Coston, Mc Isaac & Partners transactions in Moderna, Inc. stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 1,279 shares of MRNA stock, worth $43,370. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,279
Previous 119
974.79%
Holding current value
$43,370
Previous $4,000
800.0%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
863Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.37 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$867 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$846 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$603 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$253 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...